VIVO stock is up nearly 1% today after Equities research analysts gave positive predictions for the company’s current quarter.
VIVO Stock Today
On Tuesday, January 15th, Equities research analysts forecasted that Meridian Bioscience’s (NASDAQ:VIVO) earnings per share, for the current quarter, will fall at $0.18. Meanwhile, Zero analysts believe earnings will land between $0.17 to $0.19. Sure, this might not seem like a lot, but in comparison to the same quarter in 2017, it is. Last year, in the same quarter, Meridian Bioscience EPS landed at $0.15. If this were to occur, positive Y-O-Y growth would be evident. And that, ladies and gentlemen, is why the VIVO stock found its way into the green zone today.
Further, Zacks analysts forecast the company to report full-year earnings that land at $0.75 per share. In 2020, the forecast lands between $0.74 to $0.76.
For those who don’t know, Meridian Bioscience is a life science company, which develops and distributes diagnostic test kids. It operates through a couple of segments, such as Meridian Bioscience Corp. It is based in Cincinnati, Ohio and was founded in 1976 by William Motto.
>> Gold Penny Stocks: Is 2019 the Year for Profit for DRDGOLD?
Actual Numbers
According to Yahoo Finance, as of 3:22 PM, VIVO stock is up 0.96%. VIVO stock trading price is sitting at $16.91. The company has a market cap of $718.051 million.
Takeaway
What do you think about these analysts predictions? Considering the company surpassed expectations in its November 8th earnings report (it reported $0.20 EPS when the consensus estimate was $0.16), it will be interesting to see if it can do it again. If it does, will this affect VIVO stock? Probably. As a result, investors may want to keep a close eye on this company moving forward.
Let us know what you think in the comments below, though! Don’t forget to keep checking back in for more healthcare-related news! And don’t worry, we’ll be sure to follow this story closely.
Featured Image: Depositphotos © Ruliz
